Related Experiment Video
Updated: Jun 9, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment
1Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. gsv1@cdc.gov
Purpose Of Review:
Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri, although free-living amebae, also cause devastating diseases in humans leading to death. Acanthamoeba spp. and B. mandrillaris cause granulomatous amebic encephalitis, cutaneous and nasopharyngeal as well as disseminated infection. Acanthamoeba also causes a vision-threatening infection of the cornea, Acanthamoeba keratitis, principally in contact lens wearers. N. fowleri causes an acute, fulminating infection of the central nervous system, primary amebic meningoencephalitis, in healthy children and young adults who indulge in aquatic activities in fresh water. This review focuses on the recent developments in the diagnosis and treatment and clinical management of the diseases caused by these amebae.
Recent Findings:
Development of a multiplex real-time PCR test has made it possible to simultaneously detect all the three free-living amebae in a sample. It is a rapid assay with a short turn-around time of just 4-5 h. An early diagnosis would be helpful in initiating potentially effective treatment. A recent study reported exciting results indicating that loading of rokitamycin in chitosan microspheres improves and prolongs the in-vitro anti-Acanthamoeba activity of the drug.
Summary:
Diagnoses of these infections are challenging and antimicrobial therapy is empirical, which often results in fatalities. Further research is needed to explore the possibility of a better drug delivery system that crosses the blood-brain barrier and effectively reach the central nervous system.
Insights
Rapid PCR tests improve early diagnosis of deadly amebic infections caused by Acanthamoeba, Balamuthia mandrillaris, and Naegleria fowleri. Novel drug delivery systems show promise for treating these challenging central nervous system diseases.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Parasitology
Background:
- Free-living amebae, including Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri, cause severe and often fatal human diseases.
- Acanthamoeba causes granulomatous amebic encephalitis, keratitis, and disseminated infections. Naegleria fowleri causes primary amebic meningoencephalitis, a rapidly progressing CNS infection.
Purpose of the Study:
- To review recent advancements in the diagnosis and treatment of diseases caused by these three free-living amebae.
- To highlight challenges in clinical management and explore potential therapeutic strategies.
Main Methods:
- Review of recent literature on diagnostic techniques and therapeutic interventions.
- Focus on novel diagnostic assays and drug delivery systems.
Main Results:
- Development of multiplex real-time PCR for simultaneous detection of all three amebae, offering rapid diagnosis (4-5 hours).
- Chitosan microsphere loading of rokitamycin demonstrates enhanced and prolonged in-vitro anti-Acanthamoeba activity.
Conclusions:
- Diagnosis of these amebic infections remains challenging, with current antimicrobial therapy often empirical and associated with high fatality rates.
- Further research is crucial for developing improved drug delivery systems capable of crossing the blood-brain barrier to effectively treat central nervous system infections.
Related Concept Videos
Cryptococcal Meningitis
Encephalitis l: Introduction
Brain Abscess l: Introduction
Encephalitis ll: Pathophysiology
Bacterial Meningitis I: Introduction
Viral Meningitis